NeoGenomics, Inc. NEO.MX Stock
NeoGenomics, Inc. Price Chart
NeoGenomics, Inc. NEO.MX Financial and Trading Overview
NeoGenomics, Inc. stock price | 198.5 MXN |
Previous Close | 198.5 MXN |
Open | 0 MXN |
Bid | 0 MXN x N/A |
Ask | 0 MXN x N/A |
Day's Range | 198.5 - 198.5 MXN |
52 Week Range | 198.5 - 198.5 MXN |
Volume | 0 MXN |
Avg. Volume | 0 MXN |
Market Cap | 25.32B MXN |
Beta (5Y Monthly) | 1.097887 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -5.74 MXN |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
NEO.MX Valuation Measures
Enterprise Value | 25.52B MXN |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 47.801502 |
Price/Book (mrq) | 25.910456 |
Enterprise Value/Revenue | 48.165 |
Enterprise Value/EBITDA | -369.85 |
Trading Information
NeoGenomics, Inc. Stock Price History
Beta (5Y Monthly) | 1.097887 |
52-Week Change | 0% |
S&P500 52-Week Change | 20.43% |
52 Week High | 198.5 MXN |
52 Week Low | 198.5 MXN |
50-Day Moving Average | 198.5 MXN |
200-Day Moving Average | 198.5 MXN |
NEO.MX Share Statistics
Avg. Volume (3 month) | 0 MXN |
Avg. Daily Volume (10-Days) | 0 MXN |
Shares Outstanding | 127.58M |
Float | 123.28M |
Short Ratio | N/A |
% Held by Insiders | 1.42% |
% Held by Institutions | 91.05% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -23.71% |
Operating Margin (ttm) | -26.30% |
Gross Margin | 38.59% |
EBITDA Margin | -13.023% |
Management Effectiveness
Return on Assets (ttm) | -4.92% |
Return on Equity (ttm) | -12.26% |
Income Statement
Revenue (ttm) | 529.78M MXN |
Revenue Per Share (ttm) | 4.25 MXN |
Quarterly Revenue Growth (yoy) | 17.10% |
Gross Profit (ttm) | 187.9M MXN |
EBITDA | -68992000 MXN |
Net Income Avi to Common (ttm) | -125637000 MXN |
Diluted EPS (ttm) | -5.8 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 417.92M MXN |
Total Cash Per Share (mrq) | 3.28 MXN |
Total Debt (mrq) | 610.33M MXN |
Total Debt/Equity (mrq) | 62.63 MXN |
Current Ratio (mrq) | 6.755 |
Book Value Per Share (mrq) | 7.661 |
Cash Flow Statement
Operating Cash Flow (ttm) | -49645000 MXN |
Levered Free Cash Flow (ttm) | -14021125 MXN |
Profile of NeoGenomics, Inc.
Country | Mexico |
State | FL |
City | Fort Myers |
Address | 9490 NeoGenomics Way |
ZIP | 33912 |
Phone | 239 768 0600 |
Website | https://www.neogenomics.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 2100 |
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. The company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization, as well as acts as a reference laboratory supplying anatomic pathology testing services. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited. The company was founded in 2001 and is headquartered in Fort Myers, Florida.
Q&A For NeoGenomics, Inc. Stock
What is a current NEO.MX stock price?
NeoGenomics, Inc. NEO.MX stock price today per share is 198.5 MXN.
How to purchase NeoGenomics, Inc. stock?
You can buy NEO.MX shares on the Mexico exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NeoGenomics, Inc.?
The stock symbol or ticker of NeoGenomics, Inc. is NEO.MX.
Which industry does the NeoGenomics, Inc. company belong to?
The NeoGenomics, Inc. industry is Diagnostics & Research.
How many shares does NeoGenomics, Inc. have in circulation?
The max supply of NeoGenomics, Inc. shares is 127.67M.
What is NeoGenomics, Inc. Price to Earnings Ratio (PE Ratio)?
NeoGenomics, Inc. PE Ratio is now.
What was NeoGenomics, Inc. earnings per share over the trailing 12 months (TTM)?
NeoGenomics, Inc. EPS is -5.74 MXN over the trailing 12 months.
Which sector does the NeoGenomics, Inc. company belong to?
The NeoGenomics, Inc. sector is Healthcare.